Leggett & Platt Q2 Sales Beat, Adjusted EPS Rises to $0.39; Merger Vote Set for August 20
LEG sits 20% above its 52-week low of $8.32.
Summary
Leggett & Platt reported Q2 2026 sales of $1.0 billion, beating consensus, and adjusted EPS of $0.39, up from $0.30 a year ago. The company also set August 20 as the shareholder vote date for its acquisition by Somnigroup, a key step toward closing the deal.
Key Events · Earnings and Guidance · LEG
-
Q2 Sales Beat, Adjusted EPS Up 30%
Sales of $1.0 billion exceeded the $982.86 million consensus, while adjusted EPS rose to $0.39 from $0.30 in Q2 2025, driven by metal margin expansion and cost controls.
-
Adjusted EBIT Margin Expands to 8.9%
Adjusted EBIT of $89 million was up 18% year-over-year, with margin improving 180 basis points to 8.9%, reflecting operational efficiencies and favorable items not expected to repeat.
-
Merger Vote Scheduled for August 20
The special shareholder meeting to approve the Somnigroup acquisition is set for August 20, 2026. The HSR waiting period expired in June, leaving the vote and remaining regulatory approvals as the final conditions.
-
Leverage Improves to 2.57x Net Debt/EBITDA
Net debt to trailing 12-month adjusted EBITDA fell to 2.57x from 3.51x a year ago, supported by $545.8 million in cash and $1.5 billion in long-term debt.
Analysis · LEG · Manufacturing
Leggett & Platt delivered Q2 sales of $1.0 billion, beating the $982.86 million consensus, while adjusted EPS of $0.39 topped estimates. The results show operational resilience despite a 6% sales decline, driven by metal margin expansion and cost management. The company also confirmed the shareholder vote on the Somnigroup acquisition is scheduled for August 20, 2026, a critical milestone toward closing the all-stock merger. With the HSR waiting period already expired, the vote is the next major catalyst. The improved leverage ratio (2.57x net debt/EBITDA) and $545.8 million in cash provide financial flexibility, but the pending merger overshadows standalone performance.
At the time of this filing, LEG was trading at $10.00 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $8.32 to $13.00. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.